Published by Michele Maatouk on 6th December 2022
(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.
URL: http://www.digitallook.com/dl/news/story/33157548/...